GALECTIN THERAPEUTICS INC 4
4 · GALECTIN THERAPEUTICS INC · Filed Nov 19, 2014
Insider Transaction Report
Form 4
Prelack Steven
Director
Transactions
- Award
Stock option (right to buy)
2014-11-18+6,269→ 6,269 totalExercise: $3.59Exp: 2023-03-28→ Common stock (6,269 underlying) - Disposition to Issuer
Common Stock
2014-11-18−84,283→ 2,936 total - Award
Stock option (right to buy)
2014-11-18+6,168→ 6,168 totalExercise: $7.08Exp: 2021-06-28→ Common stock (6,168 underlying)
Footnotes (3)
- [F1]This Form 4 is being filed to report the rescission of certain of the Reporting Person's previous stock option exercises from January 31, 2014.
- [F2]The options are fully vested.
- [F3]The options vest quarterly in eight equal installments beginning on May 12, 2013.